dc.contributor.author |
Bedke, Jens |
|
dc.date.accessioned |
2017-11-02T16:01:56Z |
|
dc.date.available |
2017-11-02T16:01:56Z |
|
dc.date.issued |
2017 |
|
dc.identifier.issn |
1433-0563 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/78341 |
|
dc.language.iso |
de |
de_DE |
dc.publisher |
Springer Heidelberg |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1007/s00120-017-0422-4 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
Eine offene einarmige Phase-II-Monotherapiestudie zu Pembrolizumab (MK-3475) bei lokal fortgeschrittenem/metastasiertem Nierenzellkarzinom (mRCC) (Keynote-427) – AN 40/16 der AUO |
de_DE |
dc.title.alternative |
An open single-arm phase II monotherapy study of pembrolizumab (MK-3475) in locally advanced/metastatic renal cell carcinoma (mRCC) (Keynote 427) - AN 40/16 of the AUO |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20170815222223_00289 |
|
utue.publikation.seiten |
928-929 |
de_DE |
utue.personen.roh |
Rexer, H. |
|
utue.personen.roh |
Doehn, C. |
|
utue.personen.roh |
Bedke, J. |
|
dcterms.isPartOf.ZSTitelID |
Urologe |
de_DE |
dcterms.isPartOf.ZS-Issue |
7 |
de_DE |
dcterms.isPartOf.ZS-Volume |
56 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |